Actively Recruiting
Comparing Short-Course Ultrahypofractionated Radiation Therapy to Standard Radiation in Treating Resectable Soft Tissue Sarcomas of the Extremities
Led by SWOG Cancer Research Network · Updated on 2026-10-13
296
Participants Needed
67
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are comparing two types of radiation therapy for patients with soft tissue sarcomas of the arms or legs that can be removed by surgery. The study evaluates whether a shorter, more intense radiation treatment given over 5 days ultrahypofractionated radiation therapy, UHRT-5 works as well as the standard radiation treatment given over 25 days RT-25. Patients with primary or locally recurrent tumors are included, and the goal is to see if the shorter treatment can reduce tumor recurrence and improve quality of life by requiring fewer visits. Participants are randomly assigned to receive either the standard RT-25 or the shorter UHRT-5, both delivered using advanced techniques like 3-dimensional conformal radiation therapy 3D CRT or intensity-modulated radiation therapy IMRT. These therapies use computer imaging to target tumors precisely. Radiation is given once daily, five days a week. Surgery to remove the tumor is scheduled 22 to 56 days after radiation. Throughout the study, patients undergo MRI, CT scans, and blood tests to monitor their condition. Participants are followed for up to 10 years after randomization, with visits at 4 months, then every 6 months for 5 years, and yearly thereafter. The study measures local tumor recurrence at 2 years, wound healing complications, functional outcomes using a musculoskeletal scoring system, overall survival, and other long-term outcomes. Blood samples and tissue specimens are also collected for future research, and safety is carefully monitored throughout the study.
CONDITIONS
Brief Title
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here